Skip to main content
Top
Published in: Endocrine 1/2007

01-08-2007 | Case

Clinical and genetic analysis for a Chinese family with hereditary fructose intolerance

Authors: Zhen-ni Chi, Jie Hong, Jun Yang, Hui-Jie Zhang, Meng Dai, Bin Cui, Yu Zhang, Wei-qiong Gu, Yi-fei Zhang, Qiao-rui Liu, Wei-qing Wang, Xiao-ying Li, Guang Ning

Published in: Endocrine | Issue 1/2007

Login to get access

Abstract

Hereditary fructose intolerance (HFI) is an inheritable disorder of fructose metabolism, inherited as an autosomal recessive disorder and caused by catalytic deficiency of aldolase B, which is critical for gluconeogenesis and fructose metabolism. The affected individuals develop severe hypoglycemia after taking foods containing fructose and cognate sugars. The exons 2–9 of the aldolase B (gene symbol ALDOB) gene from one Chinese HFI patient were amplified by the polymerase chain reaction (PCR), and direct sequence determination was applied to the amplified fragments. The mutation of a 4-bp (AACA) deletion (479_482 del) in exon 4 of ALDOB gene was identified in the patient, which had been reported to cause a frameshift at codon 118 and a truncated protein of 132 amino acids in the previous study. Then, the second case with the same homozygote deletion and eight cases with heterozygotes had been found through screening for the mutation c.479_482 del AACA in the whole family. This is the first report of HFI with the mutation c.479_482 del AACA in the ALDOB gene in a Chinese family.
Literature
2.
go back to reference H.L. Greene, in Cecil Textbook of Medicine: Fructose Intolerance, eds. by L. Goldman, D. Ausiello (Philadelphia, Academic, 2004) H.L. Greene, in Cecil Textbook of Medicine: Fructose Intolerance, eds. by L. Goldman, D. Ausiello (Philadelphia, Academic, 2004)
4.
5.
8.
9.
11.
go back to reference R. Santamaria, M.I. Scarano, G. Esposito, et al., Eur. J. Clin. Chem. Clin. Biochem. 31, 675–678 (1993)PubMed R. Santamaria, M.I. Scarano, G. Esposito, et al., Eur. J. Clin. Chem. Clin. Biochem. 31, 675–678 (1993)PubMed
12.
go back to reference R. Santamaria, S. Tamasi, G. Del Piano, et al., J. Med. Genet. 33, 786–788 (1996)PubMed R. Santamaria, S. Tamasi, G. Del Piano, et al., J. Med. Genet. 33, 786–788 (1996)PubMed
13.
16.
go back to reference F. Lemonnier, B. Delhotal-Landes, M. Couturier, et al., J. Inherit. Metab. Dis. 10, 52–61 (1987)PubMedCrossRef F. Lemonnier, B. Delhotal-Landes, M. Couturier, et al., J. Inherit. Metab. Dis. 10, 52–61 (1987)PubMedCrossRef
17.
Metadata
Title
Clinical and genetic analysis for a Chinese family with hereditary fructose intolerance
Authors
Zhen-ni Chi
Jie Hong
Jun Yang
Hui-Jie Zhang
Meng Dai
Bin Cui
Yu Zhang
Wei-qiong Gu
Yi-fei Zhang
Qiao-rui Liu
Wei-qing Wang
Xiao-ying Li
Guang Ning
Publication date
01-08-2007
Publisher
Humana Press Inc
Published in
Endocrine / Issue 1/2007
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-007-9013-2

Other articles of this Issue 1/2007

Endocrine 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.